Literature DB >> 25054292

Metabolism and glioma therapy.

Eric C Woolf1, Adrienne C Scheck.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 25054292      PMCID： PMC6178275          DOI： 10.2217/cns.12.9

Source DB:  PubMed          Journal:  CNS Oncol        ISSN： 2045-0907


× No keyword cloud information.
  20 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Antidiabetic pharmacology: a link between metabolic syndrome and neuro-oncology?

Authors:  M Aldea; C Tomuleasa; B Petrushev; S Susman; G I Kacso; A Irimie; I S Florian; O Soritau
Journal:  J BUON       Date:  2011 Jul-Sep       Impact factor: 2.533

Review 3.  Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.

Authors:  M Kelly Nicholas; Rimas V Lukas; Steven Chmura; Bakhtihar Yamini; Maciej Lesniak; Peter Pytel
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

Review 4.  Therapeutic options for recurrent malignant glioma.

Authors:  Maximilian Niyazi; Axel Siefert; Silke Birgit Schwarz; Ute Ganswindt; Friedrich-Wilhelm Kreth; Jörg-Christian Tonn; Claus Belka
Journal:  Radiother Oncol       Date:  2010-12-13       Impact factor: 6.280

Review 5.  Current and emerging molecular targets in glioma.

Authors:  Rafael Roesler; André T Brunetto; Ana Lucia Abujamra; Caroline Brunetto de Farias; Algemir Lunardi Brunetto; Gilberto Schwartsmann
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

6.  Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy.

Authors:  Changhan Lee; Lizzia Raffaghello; Sebastian Brandhorst; Fernando M Safdie; Giovanna Bianchi; Alejandro Martin-Montalvo; Vito Pistoia; Min Wei; Saewon Hwang; Annalisa Merlino; Laura Emionite; Rafael de Cabo; Valter D Longo
Journal:  Sci Transl Med       Date:  2012-02-08       Impact factor: 17.956

Review 7.  Tumor suppressors and cell metabolism: a recipe for cancer growth.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

8.  Hypothesis: using the Warburg effect against cancer by reducing glucose and providing lactate.

Authors:  Maarten W N Nijsten; Gooitzen M van Dam
Journal:  Med Hypotheses       Date:  2009-03-04       Impact factor: 1.538

9.  IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma.

Authors:  Qi SongTao; Yu Lei; Gui Si; Ding YanQing; Han HuiXia; Zhang XueLin; Wu LanXiao; Yao Fei
Journal:  Cancer Sci       Date:  2011-11-28       Impact factor: 6.518

Review 10.  Targeting metabolic remodeling in glioblastoma multiforme.

Authors:  Amparo Wolf; Sameer Agnihotri; Abhijit Guha
Journal:  Oncotarget       Date:  2010-11
View more
  9 in total

1.  CXCL12/CXCR4 Axis Upregulates Twist to Induce EMT in Human Glioblastoma.

Authors:  Chengjun Yao; Panpan Li; Huishu Song; Fuxi Song; Yalan Qu; Xiaochen Ma; Ranran Shi; Jinsong Wu
Journal:  Mol Neurobiol       Date:  2015-07-16       Impact factor: 5.590

2.  The Clinical Implications of Human Telomerase Reverse Transcriptase Expression in Grade and Prognosis of Gliomas: a Systematic Review and Meta-analysis.

Authors:  Jing Li; Huiying Li; Jihong Liu; Bin Feng; Man Feng; Baoyu Lv; Shaomei Cheng; Xiangshan Yang
Journal:  Mol Neurobiol       Date:  2015-04-21       Impact factor: 5.590

3.  The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.

Authors:  Shunzeng Lv; Bowen Sun; Xiao Zhong; Congxin Dai; Weiping Wang; Xiaochen Ma; Huishu Song; Ranran Shi; Renzhi Wang
Journal:  Mol Neurobiol       Date:  2014-09-12       Impact factor: 5.590

4.  The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression.

Authors:  Yunyan Pan; Yanling Zhang; Lijun Chen; Yan Liu; Yanlin Feng; Junyuan Yan
Journal:  Mol Neurobiol       Date:  2015-08-06       Impact factor: 5.590

5.  The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model.

Authors:  Eric C Woolf; Kara L Curley; Qingwei Liu; Gregory H Turner; Julie A Charlton; Mark C Preul; Adrienne C Scheck
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

Review 6.  Metabolic Reprogramming in Glioma.

Authors:  Marie Strickland; Elizabeth A Stoll
Journal:  Front Cell Dev Biol       Date:  2017-04-26

7.  MicroRNA-130b promotes cell migration and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma.

Authors:  Peidong Li; Xinjun Wang; Qiao Shan; Yuehui Wu; Zhen Wang
Journal:  Oncol Lett       Date:  2017-02-22       Impact factor: 2.967

8.  EZH2 overexpression is associated with poor prognosis in patients with glioma.

Authors:  Yanyang Zhang; Xinguang Yu; Ling Chen; Zhibin Zhang; Shiyu Feng
Journal:  Oncotarget       Date:  2017-01-03

9.  The Impact of MMP-2 and Its Specific Inhibitor TIMP-2 Expression on the WHO Grade and Prognosis of Gliomas in Chinese Population: a Meta-Analysis.

Authors:  Guo-Zhong Yi; Wen-Yan Feng; Qiang Zhou; Ya-Wei Liu; Song-Tao Qi
Journal:  Mol Neurobiol       Date:  2016-01-04       Impact factor: 5.590
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.